Prelude Capital Management’s SkinHealth Systems SKIN Stock Holding History

Prelude Capital Management’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,384	Closed	-$287K	–	1313
2023 Q3	$287K	Buy	+2,384	New	+$335K	0.02%	690
2022 Q4	–	Sell	-1,369	Closed	-$323K	–	1584
2022 Q3	$323K	Sell	1,369 -1,607	-54%	-$406K	0.01%	839
2022 Q2	$765K	Sell	2,976 -292	-9%	-$78.3K	0.02%	618
2022 Q1	$1.1M	Buy	3,268 +642	+24%	+$212K	0.03%	548
2021 Q4	$1.27M	Sell	2,626 -26	-1%	-$13.4K	0.03%	498
2021 Q3	$1.38M	Buy	+2,652	New	+$1.17M	0.04%	437

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Prelude Capital Management's SKIN Position: Q4 2023 in Review

Prelude Capital Management sold out of SkinHealth Systems (SKIN) in Q4 2023, closing a stake of 2,384 shares — an estimated $287K sold.

Prelude Capital Management first reported a position in SKIN in Q3 2021 and held it in 6 quarters. The position peaked at $1.38M in Q3 2021. 130 funds tracked by Wall St. Rank hold SKIN as of Q4 2023.

Prelude Capital Management reported no remaining SkinHealth Systems position as of Q4 2023 after selling out during the quarter.
Prelude Capital Management sold 2,384 SkinHealth Systems shares in Q4 2023, an estimated $287K.
Prelude Capital Management first reported a position in SkinHealth Systems in Q3 2021 and held it in 6 quarters.
Prelude Capital Management's SkinHealth Systems position peaked at $1.38M in Q3 2021.
130 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.